In recent years, the incidence of obstetric and gynecological diseases has gradually increased. According to the "Report on Women's Health in my country", the incidence of gynecological diseases in my country is 87%, among which the incidence of endometrial cancer is second only

2024/06/0821:38:32 regimen 1272

In recent years, the incidence rate of obstetric and gynecological diseases has gradually increased. According to the "Report on Women's Health in my country", the incidence rate of gynecological diseases in my country is 87%, among which the incidence rate of endometrial cancer is second only to Cervical cancer accounts for about 20% to 30% of gynecological malignant tumors.

In recent years, the incidence of obstetric and gynecological diseases has gradually increased. According to the

In order to solve the problem of personalized medication for patients with endometrial cancer and provide guidance for prognosis judgment, Nanhua Biotechnology wholly-owned subsidiary Hunan Boai Kangmin Stem Cell Tissue Engineering Co., Ltd. has launched scientific research cooperation with Hunan Normal University in medicine. In the field of biotechnology and genetic diagnosis, the company was awarded the patent for "Kit for Predicting Endometrial Cancer Patients' Sensitivity to Chemotherapy Drugs".

It is said that Nanhua Biotechnology will promote the rapid application of technology patents and use the method and kit of the present invention to help endometrial cancer patients predict their sensitivity to chemotherapy drugs to better select appropriate and highly sensitive chemotherapy drugs. , shorten treatment time and reduce patient pain.

Xiaoxiang Morning News reporter Chen Haijun

News clue breaking channel: download the "Morning Video" client from the application market and enter the "Morning Help" topic; or call the Morning Video news hotline 0731-85571188.

regimen Category Latest News